Category Biology/Biotechnology

Neuroscientists discover Neuron type that acts as Brain’s Metronome

Metronome (stock image).
Credit: © kkolosov / Adobe Stock

By keeping the brain in sync, these long-hypothesized but never-found neurons help rodents to detect subtle sensations. By measuring the fast electrical spikes of individual neurons in the touch region of the brain, Brown University neuroscientists have discovered a new type of cell that keeps time so regularly that it may serve as the brain’s long-hypothesized clock or metronome.

This type of neuron spikes rhythmically, and in a synchronized manner, independent of external sensations, said Chris Moore, a professor of neuroscience at Brown and the associate director of the Carney Institute for Brain Science...

Read More

Researchers Wirelessly Hack ‘Boss’ Gene, a step toward Reprogramming the human Genome

Two microscope images showing the FGFR1 in its normal state and when it's activated by laser light.
The left image above shows the gene FGFR1 in its natural state. The right image shows the gene when exposed to laser light, which causes the gene to activiate and deactivate. Credit: University at Buffalo.

Advance, made possible by tiny photonic implants, could lead to new treatments for cancer, mental disorders. A new University at Buffalo-led study describes how researchers wirelessly controlled FGFR1 – a gene that plays a key role in how humans grow from embryos to adults – in lab-grown brain tissue.

The ability to manipulate the gene, the study’s authors say, could lead to new cancer treatments, and ways to prevent and treat mental disorders such as schizophrenia. The work – spearheaded by UB researchers Josep M. Jornet, Michal K. Stachowiak, Yongho Bae and Ewa K...

Read More

New research identifies gene that Hides Cancer cells from Immunotherapy

Highlights

•The early embryonic transcription factor DUX4 is active in many human cancers
DUX4-expressing cancers are characterized by low anti-tumor immune activity
•DUX4 blocks interferon-γ-mediated induction of MHC class I and antigen presentation
•DUX4 is significantly associated with failure to respond to anti-CTLA-4 therapy

A team at Fred Hutchinson Cancer Research Center has identified a gene that could make immunotherapy treatments, specifically checkpoint inhibitors, work for a wider variety of cancer patients. The study, published today in Developmental Cell, found that when the DUX4 gene is expressed in cancer cells, it can prevent the cancer from being recognized and destroyed by the immune system.

The team, led by Drs...

Read More

Red Wine’s Resveratrol could help Mars Explorers stay strong

Terminal assessment of the muscles of the triceps surae, including soleus (A)and gastrocnemius wet mass (D), soleus (B) and gastrocnemius (E) average cross sectional area (CSA), and representative images of the soleus (C) and gastrocnemius (F) muscles stained with anti-collagen VI (red), anti-slow-skeletal myosin heavy chain (green), and DAPI (blue). N = 6 per group. The results are presented as mean ± SEM; the results of the post hoc tests following the ANOVA are indicated. *p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 vs. PWB100, respectively. #p < 0.05, ###p < 0.001, and #⁢#⁢#⁢#p < 0.0001 vs. PWB100 + RSV, respectively. $p < 0.05, $$p < 0.01, and $$$p < 0.001 vs. PWB40, respectively.

Nutraceuticals that preserve muscle in reduced gravity will support long-term space mis...

Read More